Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse
about
Skeletal muscle wasting and renewal: a pivotal role of myokine IL-6Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia--can findings from animal models be translated to humans?Interleukin-6-induced satellite cell proliferation is regulated by induction of the JAK2/STAT3 signalling pathway through cyclin D1 targetingThe regulation of skeletal muscle protein turnover during the progression of cancer cachexia in the Apc(Min/+) mouse.Activity level, apoptosis, and development of cachexia in Apc(Min/+) mice.Toll-like receptor 4 mediates lipopolysaccharide-induced muscle catabolism via coordinate activation of ubiquitin-proteasome and autophagy-lysosome pathways.Muscle oxidative capacity during IL-6-dependent cancer cachexia.Overload-induced skeletal muscle extracellular matrix remodelling and myofibre growth in mice lacking IL-6Cancer cachexia, mechanism and treatmentInterleukin 6 as a key regulator of muscle mass during cachexiaSex differences in the relationship of IL-6 signaling to cancer cachexia progressionC/EBPβ mediates tumour-induced ubiquitin ligase atrogin1/MAFbx upregulation and muscle wastingActivation of the endoplasmic reticulum stress response in skeletal muscle of G93A*SOD1 amyotrophic lateral sclerosis mice.The TWEAK-Fn14 system: breaking the silence of cytokine-induced skeletal muscle wasting.Plasma from septic shock patients induces loss of muscle protein.The effect of exercise on IL-6-induced cachexia in the Apc ( Min/+) mouse.Myostatin Activates the Ubiquitin-Proteasome and Autophagy-Lysosome Systems Contributing to Muscle Wasting in Chronic Kidney DiseaseRel A/p65 is required for cytokine-induced myotube atrophy.IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the ApcMin/+ mouse.Testosterone regulation of Akt/mTORC1/FoxO3a signaling in skeletal muscle.Development of an UPLC mass spectrometry method for measurement of myofibrillar protein synthesis: application to analysis of murine muscles during cancer cachexiaMuscle mTORC1 suppression by IL-6 during cancer cachexia: a role for AMPK.Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle.Signaling mechanism of tumor cell-induced up-regulation of E3 ubiquitin ligase UBR2.Beneficial bacteria inhibit cachexia.Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humansIncreased expression of atrogenes and TWEAK family members after severe burn injury in nonburned human skeletal muscle.Mechanisms governing the health and performance benefits of exercise.Characterization of the male ApcMin/+ mouse as a hypogonadism model related to cancer cachexia.A pegylated leptin antagonist ameliorates CKD-associated cachexia in mice.Effect of nandrolone decanoate administration on recovery from bupivacaine-induced muscle injury.Short-term pyrrolidine dithiocarbamate administration attenuates cachexia-induced alterations to muscle and liver in ApcMin/+ mice.Candidate mechanisms underlying effects of contractile activity on muscle morphology and energetics in cancer cachexia.Developing models for cachexia and their implications in drug discovery.Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice.FBXO32 Targets c-Myc for Proteasomal Degradation and Inhibits c-Myc Activity.Disrupted Skeletal Muscle Mitochondrial Dynamics, Mitophagy, and Biogenesis during Cancer Cachexia: A Role for Inflammation.Levosimendan affects oxidative and inflammatory pathways in the diaphragm of ventilated endotoxemic mice.Tumor induces muscle wasting in mice through releasing extracellular Hsp70 and Hsp90.Are there any benefits of exercise training in cancer cachexia?
P2860
Q26743557-24BA268F-F7C9-423E-A691-BFA25F3CE151Q28068034-65AFC9ED-27AA-4D26-93F6-446988E17804Q28566541-DA29D660-AB82-49C5-88ED-ADEC9658D7CFQ34031423-80ABCA75-4F99-45CE-93FD-B4734BA932DCQ34236379-669351F7-155D-441D-A321-3BA3B599EA7BQ34421809-C3A8ACA0-33AF-4F23-9352-55CB609790CCQ34598672-232BC783-A55C-43D4-805B-14BA62FA2AC6Q34602991-DC0A9ED7-94E7-4E45-A322-BD58046E5707Q34669440-C0E0C766-A6BC-474D-8F0B-04A06BB0EA4CQ34727530-D031C0B7-535F-4081-8A89-A92C948E07AFQ35214154-200B954E-0FDF-4787-BD68-FCFC63C174C2Q35422257-B4247CBD-5DF4-4E26-A988-CBCA7073080FQ35617613-7B131A46-A438-4E90-94A7-0EBB172D1496Q35671234-61AEACC8-16A9-4E72-A0FB-EB94F90FC578Q35908213-F1038188-40DC-43FB-990A-9943B2EE15F7Q36028206-71C1359B-160C-474E-A9D2-729CF4A5279EQ36095662-237ED29B-E7C1-40D1-9427-C13F568ED50FQ36114658-029930C5-18A4-4632-9B7D-A02CD588F54FQ36200582-850A360F-D2EA-4C55-80AD-52B166F889F9Q36487406-CB2F33A2-8056-4C19-9C6E-ABE3FDB4923AQ36737744-960D78F8-9F00-466D-8908-932F5CA1E584Q36836194-2452506D-61F5-4166-876E-38E5A9E995B0Q36941459-3B7790D4-0F89-4B60-A793-7750F909EAB0Q36945094-288EF1E5-9E33-4904-94D2-20A977DA720EQ37022010-413821C1-CA72-47C9-8F55-9DB91B7BBB9DQ37150772-CC90B663-DB08-43ED-B703-8629DAE67BFAQ37164742-6CB3AC23-E60B-4A75-9F51-9AC4672EAAC7Q37337855-B9BFEE31-6C4B-4AD2-9148-E15EE881FA29Q37392800-5FEB8506-FC33-4DB3-8C73-E52710C79256Q37411666-2C21BCCE-AD2D-46FE-B6E7-25B8E784CD38Q37422180-F44DEDD8-AB96-4462-B9B5-F4CFB6768A61Q37644886-8471C69D-374B-44CF-909D-3FB0E5F2F451Q37924325-0D2E93DE-33F8-4CA0-9E0A-DC5E1CDF9A99Q38451282-3C4843FC-07CC-44F8-82E4-961B77BE8E23Q38606110-DE099A02-F8B9-490A-8CEE-E340A969B36FQ40972142-78E6AFA7-CBE1-49D3-A6D0-3F22949991D0Q41146515-3D241EA2-C503-4031-AF03-7FC41C63F05DQ41316270-CBCBF568-86D7-42B9-9B30-36EEA5AAFFB8Q41701219-53CDB37D-0E74-44F8-BC59-201ED4DF554BQ42199742-E16B45E3-7211-43B9-83A8-B867BB2360A6
P2860
Muscle wasting and interleukin-6-induced atrogin-I expression in the cachectic Apc ( Min/+ ) mouse
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@ast
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@en
type
label
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@ast
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@en
prefLabel
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@ast
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@en
P2093
P2860
P1433
P1476
Muscle wasting and interleukin ...... cachectic Apc ( Min/+ ) mouse
@en
P2093
Franklin G Berger
J Mark Davis
James P White
Kristen A Baltgalvis
Maria Marjorette O Peña
P2860
P2888
P304
P356
10.1007/S00424-008-0574-6
P577
2008-08-19T00:00:00Z
P5875
P6179
1027003912